Stifel Financial’s Legend Biotech LEGN Stock Holding History

Stifel Financial’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$484K	Sell	26,754 -128	-0.5%	-$2.44K	﹤0.01%	2903
2025 Q4	$584K	Sell	26,882 -8,137	-23%	-$233K	﹤0.01%	2779
2025 Q3	$1.14M	Buy	35,019 +1,544	+5%	+$57K	﹤0.01%	2319
2025 Q2	$1.19M	Buy	33,475 +654	+2%	+$21.2K	﹤0.01%	2223
2025 Q1	$1.11M	Buy	32,821 +1,456	+5%	+$52.2K	﹤0.01%	2154
2024 Q4	$1.02M	Buy	31,365 +12,955	+70%	+$537K	﹤0.01%	2223
2024 Q3	$897K	Sell	18,410 -3,635	-16%	-$194K	﹤0.01%	2304
2024 Q2	$976K	Buy	+22,045	New	+$1.02M	﹤0.01%	2181

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Stifel Financial's LEGN Position: Q1 2026 in Review

Stifel Financial reduced its Legend Biotech (LEGN) stake by 0.48% in Q1 2026, selling an estimated $2.44K and leaving 26,754 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #2903.

Stifel Financial first reported a position in LEGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.19M in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Stifel Financial held 26,754 shares of Legend Biotech worth $484K as of Q1 2026.
Stifel Financial sold 128 Legend Biotech shares in Q1 2026, an estimated $2.44K.
Legend Biotech made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2903 holding.
Stifel Financial first reported a position in Legend Biotech in Q2 2024 and has held it in 8 quarters since.
Stifel Financial's Legend Biotech position peaked at $1.19M in Q2 2025.
189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.